Rafaela S. Ferreira, Ph.D.
Affiliations: | 2010 | Chemistry and Chemical Biology | University of California, San Francisco, San Francisco, CA |
Area:
GPCR, computational chemistryGoogle:
"Rafaela Ferreira"Mean distance: 9.91
Parents
Sign in to add mentor| Brian K. Shoichet | grad student | 2010 | UCSF | |
| (Combining virtual and high-throughput screening in the discovery of new cruzain inhibitors.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cerutti JP, Diniz LA, Corrêa Santos V, et al. (2025) Thiosulfonate-Based Targeted Covalent Cruzipain Inhibitors with Enhanced Bioactivity Translation for Antichagasic Therapy. Acs Medicinal Chemistry Letters. 16: 464-474 |
| Cerutti JP, Diniz LA, Corrêa Santos V, et al. (2024) Discovery of a Potent Triazole-Based Reversible Targeted Covalent Inhibitor of Cruzipain. Acs Medicinal Chemistry Letters. 16: 72-79 |
| de Souza RA, Díaz N, G Fuentes L, et al. (2024) Assessing the Interactions between Snake Venom Metalloproteinases and Hydroxamate Inhibitors Using Kinetic and ITC Assays, Molecular Dynamics Simulations and MM/PBSA-Based Scoring Functions. Acs Omega. 9: 50599-50621 |
| Cerutti JP, Diniz LA, Santos VC, et al. (2024) Structure-Aided Computational Design of Triazole-Based Targeted Covalent Inhibitors of Cruzipain. Molecules (Basel, Switzerland). 29 |
| Pitombeira MCSR, Júnior PAS, Murta SMF, et al. (2024) New 2-nitroimidazole-N-acylhydrazones, analogs of benznidazole, as anti-Trypanosoma cruzi agents. Archiv Der Pharmazie. e2400059 |
| Serafim MSM, Kronenberger T, Rocha REO, et al. (2024) Aminopyrimidine Derivatives as Multiflavivirus Antiviral Compounds Identified from a Consensus Virtual Screening Approach. Journal of Chemical Information and Modeling |
| Santos LH, Rocha REO, Dias DL, et al. (2023) Evaluating Known Zika Virus NS2B-NS3 Protease Inhibitor Scaffolds via In Silico Screening and Biochemical Assays. Pharmaceuticals (Basel, Switzerland). 16 |
| Reis RCFM, Dos Santos EG, Benedetti MD, et al. (2023) Design and synthesis of new 1,2,3-triazoles derived from eugenol and analogues with in vitro and in vivo activity against Trypanosoma cruzi. European Journal of Medicinal Chemistry. 258: 115622 |
| Maltarollo VG, da Silva EB, Kronenberger T, et al. (2023) Structure-based discovery of thiosemicarbazones as SARS-CoV-2 main protease inhibitors. Future Medicinal Chemistry |
| Santos VC, Leite PG, Santos LH, et al. (2023) Structure-based discovery of novel cruzain inhibitors with distinct trypanocidal activity profiles. European Journal of Medicinal Chemistry. 257: 115498 |